Tianwei Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tianwei Sun has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Gan Luo
Tianjin Medical University, Tianjin, China
7 shared publicationsQiong Tang
Department of Respiratory, Tianjin Union Medical Center, Tianjin, China
7 shared publications- Xin Jin
School of Medicine, Nankai University, Tianjin 300071, China
7 shared publications Donglun Xiao
Tianjin Union Medical Center, Tianjin Medical University, Tianjin, China
5 shared publicationsHouzhi Yang
Tianjin Medical University, Tianjin, China
5 shared publicationsYonggang Fan
School of Medicine, Nankai University, Tianjin, China
5 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (11) , 1192
Unveiling the Inflammatory Role of Ependymal Cells in Spinal Cord Injury
Background: Ependymal cells are located around the central canal of the spinal cord. Although previous studies have suggested that certain ependymal cell subpopulations may contribute to astroglial scar formation following spinal cord injury (SCI), their potential involvement in post-injury inflammatory responses remains incompletely understood. Methods: In this study, single-cell RNA sequencing (scRNA-seq) identified an inflammation-associated ependymal cell subpopulation characterized by elevated expression of multiple inflammatory genes. Results: Receptor–ligand interaction analysis further predicted enhanced ligand–receptor interactions between ependymal cells and monocytes, particularly through the Thbs1-Sdc4 and Fn1-Sdc4 signaling axes at 1 day post-injury (dpi). Conclusions: These findings suggest previously underappreciated heterogeneity within ependymal cells and imply that specific subpopulations may participate in the neuroinflammatory microenvironment after SCI. Moreover, the Thbs1-Sdc4 and Fn1-Sdc4 pathways may represent potential targets for future immunomodulatory strategies following spinal cord injury.
- 30 October 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (11) , 1192
Open AccessUnveiling the Inflammatory Role of Ependymal Cells in Spinal Cord Injury
Background: Ependymal cells are located around the central canal of the spinal cord. Although previous studies have suggested that certain ependymal cell subpopulations may contribute to astroglial scar formation following spinal cord injury (SCI), their potential involvement in post-injury inflammatory responses remains incompletely understood. Methods: In this study, single-cell RNA sequencing (scRNA-seq) identified an inflammation-associated ependymal cell subpopulation characterized by elevated expression of multiple inflammatory genes. Results: Receptor–ligand interaction analysis further predicted enhanced ligand–receptor interactions between ependymal cells and monocytes, particularly through the Thbs1-Sdc4 and Fn1-Sdc4 signaling axes at 1 day post-injury (dpi). Conclusions: These findings suggest previously underappreciated heterogeneity within ependymal cells and imply that specific subpopulations may participate in the neuroinflammatory microenvironment after SCI. Moreover, the Thbs1-Sdc4 and Fn1-Sdc4 pathways may represent potential targets for future immunomodulatory strategies following spinal cord injury.
- Open Access
- 18 February 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Supramolecular delivery of senolytics enables targeted anti-senescence therapy and accelerated fracture healing
Current clinical management of fractures relies largely on surgical intervention and systemic pharmacotherapy, both of which are frequently associated with
- 18 February 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessSupramolecular delivery of senolytics enables targeted anti-senescence therapy and accelerated fracture healing
Current clinical management of fractures relies largely on surgical intervention and systemic pharmacotherapy, both of which are frequently associated with
- Open Access
- 11 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Identification and validation of palmitoylation metabolism related biomarkers in osteoarthritis using transcriptomic and single cell RNA sequencing analyses
Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage degradation and chronic inflammation, leading to pain and disability. Protein palmitoylation, a reversible lipid modification, plays a crucial role in cellular functions, but its involvement in OA remains unclear. To explore palmitoylation-related biomarkers in OA, transcriptomic and single-cell RNA sequencing analyses were performed. Machine learning algorithms and differential expression analysis identified BUB1B and KIF15 as key biomarkers, which were consistently upregulated in OA cartilage with strong diagnostic performance. Their elevated expression was validated in clinical OA samples using RT-qPCR. Functional enrichment analysis linked these biomarkers to mitotic division, chromosome segregation, and spliceosome pathways, while immune infiltration analysis suggested a role in immune modulation, with BUB1B correlating positively with immature dendritic cells and negatively with activated B cells. Further investigation identified the lncRNA XIST as a potential upstream regulator, and molecular docking analysis highlighted cyclosporine as a promising therapeutic candidate. Single-cell RNA sequencing demonstrated their differential expression across fibrocartilage, regulatory, proliferative, and homeostatic chondrocytes, suggesting cell-type-specific roles in OA progression. These findings provide new insights into the involvement of palmitoylation in OA and highlight BUB1B and KIF15 as potential biomarkers with diagnostic and therapeutic relevance.
- 11 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessIdentification and validation of palmitoylation metabolism related biomarkers in osteoarthritis using transcriptomic and single cell RNA sequencing analyses
Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage degradation and chronic inflammation, leading to pain and disability. Protein palmitoylation, a reversible lipid modification, plays a crucial role in cellular functions, but its involvement in OA remains unclear. To explore palmitoylation-related biomarkers in OA, transcriptomic and single-cell RNA sequencing analyses were performed. Machine learning algorithms and differential expression analysis identified BUB1B and KIF15 as key biomarkers, which were consistently upregulated in OA cartilage with strong diagnostic performance. Their elevated expression was validated in clinical OA samples using RT-qPCR. Functional enrichment analysis linked these biomarkers to mitotic division, chromosome segregation, and spliceosome pathways, while immune infiltration analysis suggested a role in immune modulation, with BUB1B correlating positively with immature dendritic cells and negatively with activated B cells. Further investigation identified the lncRNA XIST as a potential upstream regulator, and molecular docking analysis highlighted cyclosporine as a promising therapeutic candidate. Single-cell RNA sequencing demonstrated their differential expression across fibrocartilage, regulatory, proliferative, and homeostatic chondrocytes, suggesting cell-type-specific roles in OA progression. These findings provide new insights into the involvement of palmitoylation in OA and highlight BUB1B and KIF15 as potential biomarkers with diagnostic and therapeutic relevance.
- 6 October 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 166, 115629
Neutrophil extracellular traps promote bone loss in type 1 diabetes via suppression of the FN1–PI3K/Akt signaling axis
- 6 October 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 166, 115629
Neutrophil extracellular traps promote bone loss in type 1 diabetes via suppression of the FN1–PI3K/Akt signaling axis
- 20 February 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 410, 111436
Protosappanin B activates the Wnt pathway to protect against glucocorticoid-induced osteoblast inhibition and enhance bone formation
- 20 February 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 410, 111436
Protosappanin B activates the Wnt pathway to protect against glucocorticoid-induced osteoblast inhibition and enhance bone formation
- 10 January 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 233, 116752
5,7-Dihydroxy-4-Methylcoumarin enhances osteogenesis and ameliorates osteoporosis via the AKT1 pathway
- 10 January 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 233, 116752
5,7-Dihydroxy-4-Methylcoumarin enhances osteogenesis and ameliorates osteoporosis via the AKT1 pathway
- Open Access
- 11 December 2024
- Published by Elsevier in World Neurosurgery
- Vol. 194, 123512
Evaluation of the Therapeutic Effect of Decompression with or without Fusion on Lumbar Spinal Stenosis Caused by Degenerative Lumbar Spondylolisthesis: A Systematic Review and Meta-Analysis
- 11 December 2024
- Published by Elsevier in World Neurosurgery
- Vol. 194, 123512
Open AccessEvaluation of the Therapeutic Effect of Decompression with or without Fusion on Lumbar Spinal Stenosis Caused by Degenerative Lumbar Spondylolisthesis: A Systematic Review and Meta-Analysis
- Open Access
- 10 September 2024
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 25 (1) , 1-12
Decompression alone or fusion in single-level lumbar spinal stenosis with spondylolisthesis? A systematic review and meta analysis
Purpose: The objective of this systematic review and metaanalysis is to compare the efficacy and safety of decompression alone versus decompression plus fusion in single-level lumbar spinal stenosis with spondylolisthesis. Methods: A comprehensive search of the PubMed, Embase, Cochrane Library, and Ovid Medline databases was conducted to find randomized control trials (RCTs) or cohort studies that compared decompression alone and decompression plus fusion in single-level lumbar spinal stenosis with spondylolisthesis. Operation time; reoperation; postoperative complications; postoperative Oswestry disability index(ODI) scores and scores related to back and leg pain were collected from eligible studies for meta-analysis. Results: We included 3 randomized controlled trials and 9 cohort studies with 6182 patients. The decompression alone group showed less operative time(P < 0.001) and intraoperative blood loss(p = 0.000), and no significant difference in postoperative complications was observed in randomized controlled trials(p = 0.428) or cohort studies(p = 0.731). There was no significant difference between the other two groups in reoperation(P = 0.071), postoperative ODI scores and scores related to back and leg pain. Conclusions: In this study, we found that the decompression alone group performed better in terms of operation time and intraoperative blood loss, and there was no significant difference between the two surgical methods in rate of reoperation and postoperative complications, ODI, low back pain and leg pain. Therefore, we come to the conclusion that decompression alone is not inferior to decompression and fusion in patients with single-level lumbar spinal stenosis with spondylolisthesis.
- 10 September 2024
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 25 (1) , 1-12
Open AccessDecompression alone or fusion in single-level lumbar spinal stenosis with spondylolisthesis? A systematic review and meta analysis
Purpose: The objective of this systematic review and metaanalysis is to compare the efficacy and safety of decompression alone versus decompression plus fusion in single-level lumbar spinal stenosis with spondylolisthesis. Methods: A comprehensive search of the PubMed, Embase, Cochrane Library, and Ovid Medline databases was conducted to find randomized control trials (RCTs) or cohort studies that compared decompression alone and decompression plus fusion in single-level lumbar spinal stenosis with spondylolisthesis. Operation time; reoperation; postoperative complications; postoperative Oswestry disability index(ODI) scores and scores related to back and leg pain were collected from eligible studies for meta-analysis. Results: We included 3 randomized controlled trials and 9 cohort studies with 6182 patients. The decompression alone group showed less operative time(P < 0.001) and intraoperative blood loss(p = 0.000), and no significant difference in postoperative complications was observed in randomized controlled trials(p = 0.428) or cohort studies(p = 0.731). There was no significant difference between the other two groups in reoperation(P = 0.071), postoperative ODI scores and scores related to back and leg pain. Conclusions: In this study, we found that the decompression alone group performed better in terms of operation time and intraoperative blood loss, and there was no significant difference between the two surgical methods in rate of reoperation and postoperative complications, ODI, low back pain and leg pain. Therefore, we come to the conclusion that decompression alone is not inferior to decompression and fusion in patients with single-level lumbar spinal stenosis with spondylolisthesis.
- 9 July 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 661, 124457
Enhancing osteoporosis treatment using a targeted, sustained-release drug delivery system based on macrocyclic amphiphile
- 9 July 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 661, 124457
Enhancing osteoporosis treatment using a targeted, sustained-release drug delivery system based on macrocyclic amphiphile
- 17 November 2023
- Published by Springer Nature in Updates in Surgery
- Vol. 75 (8) , 2245-2256
Prognostic impact of colorectal cancer patients with bone metastases: a single-center experience
The incidence of bone metastasis (BM) in colorectal cancer (CRC) patients is low and the prognosis is poor. There is no clear conclusion on the risk factors affecting the survival of CRC patients with BM. The aim of this study was to investigate the factors that may affect the prognosis of CRC patients with BM. The clinical and pathological data of CRC patients with BM were retrospectively analyzed. The overall survival after BM diagnosis was estimated using the Kaplan–Meier method and Log-rank test, and a multivariable cox regression model was used to identify the prognostic factors of overall survival. This study included 178 CRC patients with BM, of whom 151 had left-sided CRC and 27 had right-sided colon cancer. 1124 CRC patients with BM from the SEER database were included to perform a sensitivity analysis of the primary outcome. Multivariate analysis showed that the N staging, site of BM, and primary tumor sidedness (PTS) were independent prognostic factors for CRC with BM. Among them, right-sided colon cancer patients with BM had a poorer prognosis. Sensitivity analyses showed that PTS was an independent prognostic factor in CRC patients with BM. Primary tumor sidedness and N stage may be potential prognostic markers for BM of CRC. The prognosis of N0 stage CRC with BM is better, while the prognosis of right-sided colon cancer is poor.
- 17 November 2023
- Published by Springer Nature in Updates in Surgery
- Vol. 75 (8) , 2245-2256
Prognostic impact of colorectal cancer patients with bone metastases: a single-center experience
The incidence of bone metastasis (BM) in colorectal cancer (CRC) patients is low and the prognosis is poor. There is no clear conclusion on the risk factors affecting the survival of CRC patients with BM. The aim of this study was to investigate the factors that may affect the prognosis of CRC patients with BM. The clinical and pathological data of CRC patients with BM were retrospectively analyzed. The overall survival after BM diagnosis was estimated using the Kaplan–Meier method and Log-rank test, and a multivariable cox regression model was used to identify the prognostic factors of overall survival. This study included 178 CRC patients with BM, of whom 151 had left-sided CRC and 27 had right-sided colon cancer. 1124 CRC patients with BM from the SEER database were included to perform a sensitivity analysis of the primary outcome. Multivariate analysis showed that the N staging, site of BM, and primary tumor sidedness (PTS) were independent prognostic factors for CRC with BM. Among them, right-sided colon cancer patients with BM had a poorer prognosis. Sensitivity analyses showed that PTS was an independent prognostic factor in CRC patients with BM. Primary tumor sidedness and N stage may be potential prognostic markers for BM of CRC. The prognosis of N0 stage CRC with BM is better, while the prognosis of right-sided colon cancer is poor.